1. Home
  2. RENX vs VIVS Comparison

RENX vs VIVS Comparison

Compare RENX & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RenX Enterprises Corp. Common Stock

RENX

RenX Enterprises Corp. Common Stock

N/A

Current Price

$1.97

Market Cap

4.7M

Sector

N/A

ML Signal

N/A

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

N/A

Current Price

$0.20

Market Cap

3.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RENX
VIVS
Founded
2021
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
3.8M
IPO Year
2023
2010

Fundamental Metrics

Financial Performance
Metric
RENX
VIVS
Price
$1.97
$0.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
118.5K
★ 587.7K
Earning Date
11-13-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $8,220,449.00
$4,603,000.00
Revenue This Year
$109.28
$228,144.28
Revenue Next Year
$53.56
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 3860.67
8.82
52 Week Low
$0.09
$0.19
52 Week High
$3.48
$3.54

Technical Indicators

Market Signals
Indicator
RENX
VIVS
Relative Strength Index (RSI) 50.58 28.24
Support Level $1.62 N/A
Resistance Level $2.10 $0.30
Average True Range (ATR) 0.20 0.02
MACD 0.02 0.00
Stochastic Oscillator 46.02 16.30

Price Performance

Historical Comparison
RENX
VIVS

About RENX RenX Enterprises Corp. Common Stock

RenX Enterprises Corp is engaged in real property development using purpose-built, prefabricated modules constructed from both wood and steel. The Company's operations mainly focused on the acquisition, entitlement, and development of residential properties in high-growth markets across the United States. These efforts included the direct acquisition of land, strategic investments in real estate entities, and joint venture partnerships targeting green, single-family, and multifamily housing projects. The company operates in four segments: real estate development, technology, compost sales, and logistics. The company generates from the compost sales.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.

Share on Social Networks: